Pmv Pharmaceuticals Stock Analysis

Pmv Stock Analysis Notes

About 81.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pmv Pharmaceuticals recorded a loss per share of 1.14. The entity had not issued any dividends in recent years. PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey. Pmv Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people. To find out more about Pmv Pharmaceuticals contact David Mack at 609 642 6670 or learn more at https://www.pmvpharma.com.

Pmv Pharmaceuticals Investment Alerts

Pmv Pharmaceuticals Upcoming and Recent Events

Pmv Largest EPS Surprises

View All Earnings Estimates

Pmv Stock Institutional Investors

Note, although Pmv Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pmv Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 64.4 M.

Pmv Profitablity

Management Efficiency

Pmv Pharmaceuticals has return on total asset (ROA) of (0.2392) % which means that it has lost $0.2392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2923) %, meaning that it created substantial loss on money invested by shareholders. Pmv Pharmaceuticals' management efficiency ratios could be used to measure how well Pmv Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/24/2025, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.51. At this time, Pmv Pharmaceuticals' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 03/24/2025, Non Current Liabilities Other is likely to grow to about 16.2 M, while Total Current Liabilities is likely to drop slightly above 10.2 M.

Technical Drivers

As of the 24th of March, Pmv Pharmaceuticals holds the Coefficient Of Variation of (802.86), risk adjusted performance of (0.11), and Variance of 6.41. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pmv Pharmaceuticals, as well as the relationship between them.

Pmv Pharmaceuticals Price Movement Analysis

Pmv Pharmaceuticals Insider Trading Activities

Pmv Pharmaceuticals Outstanding Bonds

Pmv Pharmaceuticals Predictive Daily Indicators

Pmv Pharmaceuticals Forecast Models

Pmv Pharmaceuticals' time-series forecasting models are one of many Pmv Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pmv Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pmv Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pmv shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pmv Pharmaceuticals. By using and applying Pmv Stock analysis, traders can create a robust methodology for identifying Pmv entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pmv analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pmv analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pmv Pharmaceuticals stock analysis indicators help investors evaluate how Pmv Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pmv Pharmaceuticals shares will generate the highest return on investment. By understating and applying Pmv Pharmaceuticals stock analysis, traders can identify Pmv Pharmaceuticals position entry and exit signals to maximize returns.

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.